Find our latest news and company updates and access our digital media assets here.
For all media inquiries, contact us at communications@sonicincytes.com or refer to our Media Kit for more information.
Sonic Incytes Medical Corp. is pleased to present its breakthrough liver health assessment solution, VelacurTM, at the Digital Medicine &...
At Sonic Incytes, we believe in creating accessible and affordable solutions for healthcare providers – with health insights they can...
At the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting 2020, Sonic Incytes presented the results...
During The Liver Meeting Digital Experience™ 2020, Sonic Incytes Medical Corp. invites you to a professional development webinar series starting...
Sonic Incytes Medical Corporation is pleased to announce the US commercial release of VelacurTM, the world’s first handheld 3D liver...
Join Sonic Incytes at AASLD’s The Liver Meeting 2020, November 13-16, to find out more about how we’re creating accessible...
Sonic Incytes is proudly presenting at the EASL Digital International Liver CongressTM, August 27-29, 2020.
Genome BC is pleased to announce $1 million in funding to Sonic Incytes Medical Corp., completing the company’s seed financing...
Sonic Incytes Medical Corp. is pleased to announce it has been selected to participate in the Canadian Technology Accelerator (CTA)...
Poised for success with its breakthrough, handheld ultrasound solution for assessing and monitoring chronic liver disease, Sonic Incytes Medical Corp....